Developer of connected intravascular medical device designed to help facilitate the treatment of cardiac arrhythmia. The company utilizes artificial intelligence (AI) and real-time tissue analysis through advanced four-dimensional imaging and improves structural heart interventions, enabling doctors to perform cardiac treatments that improve outcomes for patients, increase procedural safety, and reduce the cost to the healthcare system.
Developer of an artificial intelligence-based healthcare technology designed to assist clinicians in detecting and diagnosing cancer. The company's technology develops imaging and multi-omics biomarkers and reporting tools using artificial intelligence and MRI, to support cancer screening and diagnosis, enabling clinicians and physicians to make cancer detection accurate, accessible, cost-effective, and quick.
Developer of electrophysiology and structural heart devices designed to treat patients suffering from complex chronic cardiac, stroke and arrhythmia risk diseases. The company's devices are built around custom left atrial appendage occluder implants that provide synergistic modules like cardiac monitoring, ablation, or both modules, enabling medical professionals to offer cost-benefit treatments without the need for anti-coagulants and anti-arrhythmic medicines resulting in significant improvements in patient outcomes.
Developer of a medical device designed to help physicians treat atrial fibrillation. The company develops a medical device that selectively targets the origin of the problem from outside rather than inside the heart and uses a catheter to deliver short pulses of electrical energy into the clusters of neuronal cells, enabling patients to avail of the treatment without damaging the heart muscle.